Slide 1: Company Presentation ASX announcement cover note
Micro-X Limited, ABN 21 153 273 735 COMPANY PRESENTATION Micro-X management attending corporate, partnering and investor meetings in the EU and US For personal use only Adelaide, Australia, 21 March 2022: Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cat
Slide 2: Corporate Presentation: Clear Vision, Focused Execution
For personal use only ACN 153 273 735 / ASX: MX1 C O R P O R AT E P R E S E N TAT I O N CLEAR VISION FOCUSED EXECUTION 21 March2022 Peter Rowland Managing Director & CEO Kingsley Hall CFO & Company Secretary
Slide 3: Important Notice
I M P O R TA N T N O T I C E For personal use only S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, fina
Slide 4: Miniaturizing X-ray
MINIATURIZING X-RAY First Mover in Next Generation X-ray for Global Health and Security Markets For personal use only Platform technology in cold cathode x-ray • X-ray products with significant reduction in size, weight and power • Patented technology – platform for health and new security applicati
Slide 5: Cold-Cathode Is the Future of X-ray
COLD-CATHODE IS THE FUTURE OF X-RAY Strong technology advantages For personal use only 1st FIRST TO MARKET SUPERIOR PERFORMANCE Micro-X is first to market with a Proven performance, reliability proven, Cold Cathode, Medical and lifetime of patented X-Ray product technology in production in Adelaide,
Slide 6: Corporate Snapshot
C O R P O R AT E S N A P S H O T Growth Stage Company with strong Institutional / Pension Fund support For personal use only Key Financials & Shareholders Share Register Cash ~A$19.9m (US$14.4m) (31 December 2021) – Debt free Retail and HNW A$3.8m (US$2.8m) (FY2021) 54.6% Revenue A$1.5m (US$1.1m) (1
Slide 7: Strategy: Monetize Our First Mover Advantage
S T R AT E G Y M O N E T I Z E O U R ‘ F I R S T M O V E R ’ A D VA N TA G E Successful first movers in breakthrough For personal use only technology move quickly: Early Commercial success becomes a barrier commercial domination to entry for others OUR GOAL Four global production lines: - common tec
Slide 8: One Company – Four Businesses
O N E C O M PA N Y – F O U R B U S I N E S S E S Each unique product drives a new market-focused Business Unit For personal use only Mobile DR Cameras Checkpoints CT First Sales First Sales First Sales First Sales 2018 H2 2022 2024 2026 Addressable Market Addressable Market Addressable Market Addres
Slide 9: Established Capabilities
E S TA B L I S H E D C A PA B I L I T I E S Key Disciplines – Engineering Design, Development and Manufacturing For personal use only 8
Slide 10: Experienced Leadership
EXPERIENCED LEADERSHIP Technical and Commercial Expertise to support our objectives For personal use only Jim McDowell Non-Executive Director • Extensive experience in Defence and Aerospace industries • Current CEO of Nova Group David Knox • Former Chief Executive of the Department of Premier for St
Slide 11: Mobile DR Business Unit
For personal use only MOBILE DR BUSINESS UNIT D r i v i n g P o i n t- o f- C a r e I m a g i n g F u r t h e r
Slide 12: Mobile Digital Radiology
MOBILE DIGITAL RADIOLOGY Extending Bedside Imaging with Lightweight and Ultra-mobility For personal use only THE PRODUCT RANGE $3.6m (US$2.8m) • OEM Products – ‘Carestream DRX-Revolution Nano’ • First sold 2018 – now operating in 20+ countries Sales FY21 • Other OEM partnerships in development 30 Mi
Slide 13: Mobile DR – Controlling Our Destiny
MOBILE DR – CONTROLLING OUR DESTINY Building Commercial Capability – New Markets and Sales Channels For personal use only Strategy o Direct Sales executives – deep relationships in radiology and equipment sales o Independent Distributors and Dealerships - in all key markets – non-exclusive o Major O
Slide 14: Mobile DR – Major Launch & Rebranding
MOBILE DR - MAJOR LAUNCH & REBRANDING RSNA – Largest Global Radiology Conference – 29 November 2021 For personal use only Showcasing Micro-X branding, Gen 2 product range & Tubes for Life warranty 13
Slide 15: X-ray Camera Business Unit
For personal use only X-RAY CAMERA BUSINESS UNIT S a v i n g L i v e s b y S e e i n g D i f f e r e n t l y
Slide 16: X-ray Camera – Revolutionizing Bomb Disposal
X-RAY CAMERA-REVOLUTIONIZING BOMB DISPOSAL Saving lives in the world’s most dangerous workplace For personal use only Global Problem – all IED Assessment with conventional x-ray requires placing a separate imaging detector Current practice is for technician to be ‘Over the Target’ with huge risk to
Slide 17: X-ray Camera – 'Argus'
X-RAY CAMERA – ‘ARGUS’ Demonstrated capability driving strong customer interest For personal use only Key features are unparalleled World’s most sophisticated bomb detector without a separate imaging detector Self-contained ‘camera’ carried by EOD robot for remote viewing High resolution image allow
Slide 18: X-ray Camera – Commercial Execution
X-RAY CAMERA – COMMERCIAL EXECUTION 2022 will be a pivotal year – customer trials commence shortly with sales by mid 2022 For personal use only Q3-Q4 2021 Q2 2022 Global Product Launch Trade shows – UK and USA – US IABTI Conference, July 2022 RFIs to Aust Defence and UK Ministry Defence Argus Pre-pr
Slide 19: X-ray Camera – Preparing for 2022 Launch
X-RAY CAMERA – PREPARING FOR 2022 LAUNCH Pre-launch marketing to building awareness and sales pipeline For personal use only Target addressable market is US$1.8B Police (urban counter-terrorism), Military (counter-IED), Border Forces (contraband) o Globally there are 3,000 counter-IED units* o 468 P
Slide 20: Checkpoints Business Unit
For personal use only CHECKPOINTS BUSINESS UNIT A B e t t e r E x p e r i e n c e f o r Tr a v e l e r s
Slide 21: Checkpoints – Transforming Travel
CHECKPOINTS – TRANSFORMING TRAVEL Self service checkpoints – Speed and safety for future travelers For personal use only Customer driven concept to improve travel experience Passenger self-directed screening – integrates with passport scanning, photometric ID, body scan, baggage CT Automation will i
Slide 22: Checkpoint – Core Technology Advantages
CHECKPOINT – CORE TECHNOLOGY ADVANTAGES Enabled by Cold Cathode X-ray – proven by UK Future Aviation Security contract For personal use only Technology enabler Micro-X CNT technology enables miniaturized high- resolution dual-energy CT scanners – size and speed Successful UK concept demonstration –
Slide 23: Checkpoints – Commercial by 2023
CHECKPOINTS – COMMERCIAL BY 2023 Funded by two Contracts with US Dept. of Homeland Security - US$4m For personal use only Miniaturized CT – Baggage scanner Compelling value proposition for DHS Full Self-Service Portal TSA operates 2,200 x-ray lanes across 440 airports in the United States* TSA manpo
Slide 24: Checkpoint – Partners
CHECKPOINT –PARTNERS Micro-X is taking Leadership Role, Prime Contracting with our Collaborators For personal use only Developing Transformative Leading a Global Engaging with Regulators Actively Participating Core Technology Team of Innovators and Customers Industry Work Shops: Real-time Mm- Automa
Slide 25: CT Business Unit
For personal use only CT BUSINESS UNIT C T s o S m a l l i t c a n F l y
Slide 26: CT – A New Standard of Care for Stroke
CT - A NEW STANDARD OF CARE FOR STROKE Taking stroke diagnosis from the hospital to the ambulance For personal use only Market opportunity for mobile stroke diagnosis is US$5B 48,000 Road Ambulances in North America and 60,000 in Europe Air ambulances and other mobile healthcare applications Goal to
Slide 27: CT – Stroke Diagnosis Using Micro-X CNT
CT –STROKE DIAGNOSIS USING MICRO-X CNT Enabling highly mobile and miniature X-Ray imaging for stroke diagnosis For personal use only Current technology – large and heavy Micro-X CNT delivers perfect solution – small and mobile A conventional CT gantry spins at 200rpm Mobile CT with 29 mini X-ray tub
Slide 28: CT – Commercial Product in Years
CT – COMMERCIAL PRODUCT IN 4 YEARS A$8m Australian Government MRFF programme – Stroke Golden Hour For personal use only $8m funding from Australian Stroke Alliance Robust CT imager with no moving parts – small enough and affordable to be fitted to every ambulance (land & air) Micro-X CT Scanner expe
Slide 29: Overview of Micro-X: Milestones & Achievements
OVERVIEW OF MICRO-X MILESTONES & ACHIEVEMENTS Next generation X-ray for global health and security markets INITIATIVES TO DELIVER COMMERCIAL OUTCOMES FOR ALL STAKEHOLDERS For personal use only Next generation ‘Rover Mk II’’ – CE Mark and FDA clearance Strong growth in Mobile DR sales – US and EU foc
Slide 30: Summary – Four Significant Businesses
SUMMARY - FOUR SIGNIFICANT BUSINESSES Core cold cathode nanotube technology is proven and is the key enabler For personal use only Mobile DR - Healthcare X-Ray Camera - Security • Medical, Military and Veterinary • Saving the lives of bomb techs • Customers – hospitals, military, vets • Total addres
Slide 31: Thank You
ACN 153 273 735 / ASX: MX1 For personal use only THANK YOU